Xponance’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $517K | Sell |
45,836
-3,428
| -7% | -$38.6K | ﹤0.01% | 937 |
|
|
2025
Q1 | $497K | Sell |
49,264
-55
| -0.1% | -$555 | ﹤0.01% | 929 |
|
|
2024
Q4 | $583K | Buy |
49,319
+2,607
| +6% | +$30.8K | 0.01% | 907 |
|
|
2024
Q3 | $539K | Buy |
46,712
+9,740
| +26% | +$112K | 0.01% | 914 |
|
|
2024
Q2 | $391K | Sell |
36,972
-34,328
| -48% | -$363K | ﹤0.01% | 979 |
|
|
2024
Q1 | $752K | Buy |
71,300
+25,415
| +55% | +$268K | 0.01% | 808 |
|
|
2023
Q4 | $515K | Sell |
45,885
-919
| -2% | -$10.3K | 0.01% | 922 |
|
|
2023
Q3 | $547K | Buy |
46,804
+13,291
| +40% | +$155K | 0.01% | 855 |
|
|
2023
Q2 | $338K | Buy |
+33,513
| New | +$338K | ﹤0.01% | 1020 |
|